Examining data from over 850,000 adults in 38 states—including those that have legalized recreational cannabis—the investigators utilized responses from the Behavioral Risk Factor Surveillance System, a robust, annual health behavior survey administered by the Centers for Disease Control and Prevention. Respondents reported their cannabis and tobacco use frequencies over the preceding 30 days, allowing classification into distinct groups: users of neither substance, those using tobacco only, cannabis only, and those using both concurrently.

Statistical analysis reveals a fascinating trend: while sole tobacco and sole cannabis use remained relatively stable—hovering around 14% and 7%, respectively—the concurrent use of tobacco and cannabis has shown a modest but consistent increase, rising from just over 4% to nearly 5.5%. This uptick in co-use raises significant public health concerns given existing evidence that simultaneous consumption exacerbates risks of dependency and may potentiate adverse health outcomes beyond those observed with either substance alone.

The temporal association of these trends with cannabis legalization is of particular note. Post-legalization, the odds of exclusive cannabis use rose by 88%, and concurrent use with tobacco increased by 44%, albeit with a corresponding 13% decline in tobacco-only use. This suggests a substitution and convergence effect in substance use behaviors. Importantly, these dynamics vary substantially across demographic sectors. Young adults (18–24 years) exhibited the largest increases in cannabis use, exceeding 6%, while notable rises were also documented among older adults aged 65 and above—a demographic traditionally characterized by lower rates of cannabis consumption.

Further dissection illustrates that cannabis use escalated among individuals with at least a high school education, a group previously exhibiting lower recreational cannabis engagement. Concurrently, the prevalence of dual substance use also rose in this more educated cohort. In contrast, tobacco use declined more sharply among women compared to men, illuminating gender-specific trajectories in response to policy shifts.

Crucially, mental health emerges as a significant modifier of these trends. Adults reporting poor mental health experienced larger increases in cannabis use and concurrent use behaviors, aligning with prior literature linking substance use patterns with psychological distress. Conversely, this group also showed a more pronounced decline in tobacco-only use, hinting at complex substitution dynamics that warrant further mechanistic exploration.

Geographical disparities also underscore the variability in substance use prevalence. States such as Massachusetts reported sole tobacco use as low as 8%, whereas West Virginia observed rates exceeding 26%. Meanwhile, concurrent tobacco and cannabis use ranged widely, from approximately 3% in Utah to 9.5% in Alaska. These observations highlight the contextual influence of local culture, policy environment, and retail accessibility on consumption behaviors.

The introduction of licensed recreational cannabis retail outlets further intensified trends toward increased cannabis and concurrent use. Availability and normalization of cannabis products through these channels likely facilitate higher consumption, amplified by shifts in public perception about cannabis safety. However, despite these associations, causality cannot be definitively established due to the observational nature of the study and intrinsic limitations of the dataset, including reliance on self-reported data and incomplete coverage of all states.

It is worth noting that the data collection tool—the Behavioral Risk Factor Surveillance System—does not capture critical variables such as the method, timing, or frequency of simultaneous substance use, constraining in-depth behavioral analyses. Additionally, the average response rates per state ranged between 44% and 50%, introducing potential nonresponse bias which may skew prevalence estimates.

Despite these constraints, the study contributes substantially to a growing corpus of evidence suggesting that cannabis legalization and expanded retail access transform patterns of substance use. These changes potentially narrow historical disparities in cannabis use by elevating consumption among groups less traditionally inclined to use, rather than reflecting declines among higher-risk populations. This realignment has profound implications for public health surveillance, prevention strategies, and regulatory frameworks.

The authors caution that ongoing policy evolution demanding increased cannabis access intersects with persistent tobacco control measures, presenting a paradox where tobacco use declines even as co-use with cannabis rises. This suggests multifactorial pathways influenced by legal, social, and individual determinants, warranting multidisciplinary investigative approaches to unravel underlying mechanisms.

In conclusion, as states continue to legalize and commercialize recreational cannabis, a vigilant eye must be kept on the intertwined epidemiology of cannabis and tobacco use. Balanced public health responses need to consider the complexities of polysubstance use, the evolving socio-legal landscape, and demographic disparities to mitigate potential increases in dependence and adverse health consequences linked to concurrent substance consumption.

—

Subject of Research: People

Article Title: Associations between recreational cannabis legalisation and disparities in use and co-use of tobacco and cannabis

News Publication Date: 9-Feb-2026

Web References:
– Behavioral Risk Factor Surveillance System (BRFSS): https://www.cdc.gov/brfss/index.html
– DOI of the article: http://dx.doi.org/10.1136/tc-2025-059748

Keywords: Cannabis, Tobacco, Legislation

The methodology underpinning this research is notable for its nuanced approach to data linkage. Participants were not required to be aware of cannabis store locations; instead, the researchers ingeniously linked respondents’ ZIP codes with licensed retailer addresses. This geographical mapping enabled a precise assessment of local cannabis retail density and proximity, facilitating an objective measure of exposure to cannabis commercial access without relying on participants’ subjective knowledge. Consequently, this approach strengthens the validity of the associations identified between local retail environments and individual substance use behaviors.

Kerr emphasizes that participants residing in areas dense with licensed cannabis retailers demonstrated a significantly higher probability of using cannabis at least ten days per month. This frequency denotes a level of consumption suggestive of established habitual use rather than casual or experimental engagement. Intriguingly, the data also revealed a concurrent reduction in heavy alcohol consumption, defined by the U.S. Centers for Disease Control and Prevention as eight or more alcoholic drinks per week for women and fifteen or more for men. This inverse relationship between cannabis and alcohol use patterns underscores a complex interplay between substance availability and user preferences or behaviors in the context of legal cannabis markets.

Demographic stratification of the findings unveiled age-related nuances, with the strongest effects observed among individuals aged 21 to 24 and those aged 65 and older. The younger cohort represents a critical developmental window wherein the brain, particularly regions vulnerable to the neurotoxic effects of substances, continues to mature. Kerr highlights that this age group corresponds to the peak risk period for the onset of cannabis use disorder, a clinical condition characterized by problematic rather than recreational use of cannabis that impairs various life domains. This raises public health concerns about early exposure and high-frequency use patterns potentially resulting from intensified retail access.

Conversely, older adults showed increased cannabis use in conjunction with diminished perceptions of cannabis-related harms. The study suggests that seniors, particularly those managing chronic illnesses, may increasingly adopt cannabis, often motivated by symptomatic relief or as an opioid alternative. Yet, Kerr cautions that the evidence base supporting many medicinal claims remains insufficient, and non-evidence-based or inappropriate use could precipitate novel health risks. This recognition calls for careful clinical guidance and age-specific interventions to navigate the therapeutic versus harmful potential of cannabis among aging populations.

Crucially, Kerr insists that living near cannabis retailers does not necessarily equate with a deliberate choice predicated on cannabis access. Instead, it is more plausible that the saturated retail environment influences behavioral norms and availability heuristics, thereby modulating consumption tendencies. This environmental effect is particularly relevant in regions where recreational cannabis sales have been legally sanctioned since 2015, creating new dynamics in substance use epidemiology and community exposure.

The research also highlights policy implications rooted in these behavioral findings. Kerr advocates for multilayered, age-informed prevention strategies that respond to evidence demonstrating the marketing of cannabis products and retail experiences heavily geared toward young adults. These strategies might encompass stricter retail zoning laws, potency regulations, or targeted educational campaigns aimed at mitigating high-risk use while balancing public health goals against consumer autonomy and economic interests.

Furthermore, the study draws attention to the divergent trajectories and needs of different age groups, emphasizing that a singular regulatory approach may not suffice. Young adults require interventions addressing neurodevelopmental susceptibility and disorder prevention, while older adults may benefit from clinical oversight to ensure safe, effective cannabis utilization, minimizing unintended adverse impacts or interactions with other medications.

Kerr’s work advances the broader discourse on cannabis legalization impacts by underscoring the duality of substance substitution phenomena: increased cannabis use might conversely reduce harmful patterns of alcohol consumption, a leading contributor to morbidity and mortality globally. This complex substitution effect could potentially offset some public health burdens traditionally attributed to alcohol, although the net population health impact remains a subject for ongoing investigation.

Acknowledging that cannabis legalization and retail proliferation remain relatively recent phenomena, Kerr underscores the importance of longitudinal surveillance and adaptive policy frameworks. Robust data collection mechanisms and interdisciplinary research will be critical to understanding evolving consumption trends, health outcomes, and social equity implications arising from expanding cannabis access.

This study’s contribution is amplified by its scale, methodological rigor, and focus on real-world retail access, positioning it as a pivotal resource informing evidence-based policymaking. Supported by the National Institute on Drug Abuse, these findings resonate beyond Oregon, offering valuable insights to states and countries grappling with the epidemiological and regulatory complexities of legal cannabis markets worldwide.

In sum, Oregon’s experience with legalized cannabis retail elucidates a nuanced behavioral landscape shaped by proximity to cannabis stores. Its implications reverberate across public health, clinical practice, and policy fields, demanding sophisticated, tailored responses that protect vulnerable populations while acknowledging the shifting cultural and substance use paradigms of the 21st century.

Subject of Research: People

Article Title: Oregon Adults’ Cannabis and Alcohol Use Associations with Local Cannabis Retail Access, 2014-2022

News Publication Date: 22-Oct-2025

Web References: American Journal of Preventive Medicine DOI

References:
Kerr, D. et al. (2025). Oregon Adults’ Cannabis and Alcohol Use Associations with Local Cannabis Retail Access, 2014-2022. American Journal of Preventive Medicine. DOI:10.1016/j.amepre.2025.108164

Image Credits: Cannabis sativa, Oregon State University

Keywords: Cannabis retail access, cannabis use, alcohol consumption, Oregon, legalization, behavioral epidemiology, cannabis use disorder, public health policy, substance substitution, age-related risk, chronic illness, prevention strategies